Literature DB >> 35224006

Renoprotective Role of Hypoxia-Inducible Factors and the Mechanism.

Qiu-Yu Li1, Fei Liu1, Xiaoxiao Tang1, Haidong Fu1, Jianhua Mao1.   

Abstract

BACKGROUND: The kidney requires abundant blood supply, and oxygen is transmitted by diffusion through blood vessels. Most physiological metabolism of the kidney depends on oxygen, so it is very sensitive to oxygen. An increasing pool of evidence suggests that hypoxia is involved in almost all acute and chronic kidney diseases (CKDs). Vascular damage, tubular injury, and fibrosis are the main pathologies associated during hypoxia. Hypoxia-inducible factors (HIFs) are the main mediators during hypoxia, but their functions remain controversial. This article reviewed recent studies and described its mechanisms on renoprotection.
SUMMARY: HIF is degraded rapidly during under normal oxygen. But under hypoxia, HIFs accumulate and many target genes are regulated by HIFs. Homeostasis during injury is maintained through these genes. Pretreatment of HIF can protect the kidney from acute hypoxia and can improve repair, but HIF's role in CKD and in renal tumor is still controversial. Due to its mechanism in kidney disease, many drugs toward HIFs are widely researched, even some of which have been used in clinical or in clinical research. KEY MESSAGES: In this review, we described the known physiological mechanisms, target genes, and renal protective roles of HIFs, and we discussed several drugs that are researched due to such renal protective roles.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Effect; Hypoxia; Hypoxia-inducible factors; Kidney disease; Mechanism

Year:  2021        PMID: 35224006      PMCID: PMC8820168          DOI: 10.1159/000520141

Source DB:  PubMed          Journal:  Kidney Dis (Basel)        ISSN: 2296-9357


  99 in total

Review 1.  Passing the baton: the HIF switch.

Authors:  Mei Yee Koh; Garth Powis
Journal:  Trends Biochem Sci       Date:  2012-07-18       Impact factor: 13.807

2.  Vascular geometry and oxygen diffusion in the vicinity of artery-vein pairs in the kidney.

Authors:  Jennifer P Ngo; Saptarshi Kar; Michelle M Kett; Bruce S Gardiner; James T Pearson; David W Smith; John Ludbrook; John F Bertram; Roger G Evans
Journal:  Am J Physiol Renal Physiol       Date:  2014-09-10

3.  Upregulation of microRNA-210 regulates renal angiogenesis mediated by activation of VEGF signaling pathway under ischemia/perfusion injury in vivo and in vitro.

Authors:  Fen Liu; Yuan-Lei Lou; Jue Wu; Qiong-Fang Ruan; An Xie; Fei Guo; Su-Ping Cui; Zhi-Feng Deng; Yang Wang
Journal:  Kidney Blood Press Res       Date:  2011-11-25       Impact factor: 2.687

Review 4.  Sodium-glucose cotransport.

Authors:  Søren Brandt Poulsen; Robert A Fenton; Timo Rieg
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-09       Impact factor: 2.894

Review 5.  Hypoxia-inducible factor-1α: a promising therapeutic target for autoimmune diseases.

Authors:  Shi-Yang Guan; Rui-Xue Leng; Jin-Hui Tao; Xiang-Pei Li; Dong-Qing Ye; Nancy Olsen; Song Guo Zheng; Hai-Feng Pan
Journal:  Expert Opin Ther Targets       Date:  2017-06-05       Impact factor: 6.902

6.  Myeloid cell-derived hypoxia-inducible factor attenuates inflammation in unilateral ureteral obstruction-induced kidney injury.

Authors:  Hanako Kobayashi; Victoria Gilbert; Qingdu Liu; Pinelopi P Kapitsinou; Travis L Unger; Jennifer Rha; Stefano Rivella; Detlef Schlöndorff; Volker H Haase
Journal:  J Immunol       Date:  2012-04-06       Impact factor: 5.422

Review 7.  HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.

Authors:  Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  Nat Rev Nephrol       Date:  2015-12-14       Impact factor: 28.314

Review 8.  The SLC2 (GLUT) family of membrane transporters.

Authors:  Mike Mueckler; Bernard Thorens
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

9.  Substrate-Trapped Interactors of PHD3 and FIH Cluster in Distinct Signaling Pathways.

Authors:  Javier Rodriguez; Ruth Pilkington; Amaya Garcia Munoz; Lan K Nguyen; Nora Rauch; Susan Kennedy; Naser Monsefi; Ana Herrero; Cormac T Taylor; Alex von Kriegsheim
Journal:  Cell Rep       Date:  2016-03-10       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.